Drug Discovery

The novel fusogenic peptides improve the delivery of therapeutics for ovarian cancer through their ability to enhance endosomal escape and...

Clemson University and Emory University researchers have partnered up to uncover the efficacy that Ibrutinib can have in targeting and reversing the...

Clemson University researchers have developed a new family of modified small molecules that include bisbenzimidazole derivatives as antimicrobials and topoisomerase...

In order to fill the gaps in existing biomedical knowledge, Clemson University researchers have developed MOLIERE, which utilizes information from...

Clemson researchers have developed novel compounds that are active against trypanosomiasis and other parasitic infections, offering an avenue for dramatically...